Home Applications 216908 Application 216908
Type ANDA
Sponsor TP ANDA HOLDINGS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 NAPROXEN NAPROXEN TABLET, DELAYED RELEASE;ORAL 375MG No No 002 NAPROXEN NAPROXEN TABLET, DELAYED RELEASE;ORAL 500MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A216908-001 NAPROXEN NAPROXEN 375MG TABLET, DELAYED RELEASE / ORAL AB 2023-05-31 A216908-002 NAPROXEN NAPROXEN 500MG TABLET, DELAYED RELEASE / ORAL AB 2023-05-31
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 52 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2023-12-20 04:57 UTC 2023-12 A216908-001 NAPROXEN 375MG TABLET, DELAYED RELEASE / ORAL AB 2023-05-31 ea1830bbd6c7…2023-12-20 04:57 UTC 2023-12 A216908-002 NAPROXEN 500MG TABLET, DELAYED RELEASE / ORAL AB 2023-05-31 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A216908-001 NAPROXEN 375MG TABLET, DELAYED RELEASE / ORAL AB 2023-05-31 a72a2bbeb626…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A216908-002 NAPROXEN 500MG TABLET, DELAYED RELEASE / ORAL AB 2023-05-31 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A216908-001 NAPROXEN 375MG TABLET, DELAYED RELEASE / ORAL AB 2023-05-31 9b2671bbb829…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A216908-002 NAPROXEN 500MG TABLET, DELAYED RELEASE / ORAL AB 2023-05-31 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A216908-001 NAPROXEN 375MG TABLET, DELAYED RELEASE / ORAL AB 2023-05-31 a67488948f0b…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A216908-002 NAPROXEN 500MG TABLET, DELAYED RELEASE / ORAL AB 2023-05-31 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A216908-001 NAPROXEN 375MG TABLET, DELAYED RELEASE / ORAL AB 2023-05-31 3f0d92c62455…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A216908-002 NAPROXEN 500MG TABLET, DELAYED RELEASE / ORAL AB 2023-05-31 3f0d92c62455…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A216908-001 NAPROXEN 375MG TABLET, DELAYED RELEASE / ORAL AB 2023-05-31 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A216908-002 NAPROXEN 500MG TABLET, DELAYED RELEASE / ORAL AB 2023-05-31 a50c72e98297…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 52 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Naproxen NAPROXEN TruPharma LLC 004bb832-29d5-add0-e063-6394a90a90f4 2026-10-01 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 216908 application number: ANDA216908
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.